SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-018932
Filing Date
2016-05-10
Accepted
2016-05-10 16:05:22
Documents
3
Period of Report
2016-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arwr-8k_20160510.htm 8-K 27446
2 EX-99.1 arwr-ex991_6.htm EX-99.1 242712
3 GRAPHIC gz1mohkxxymf000001.jpg GRAPHIC 3238
  Complete submission text file 0001564590-16-018932.txt   276238
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-21898 | Film No.: 161635739
SIC: 8731 Services-Commercial Physical & Biological Research